1
|
Ontaneda D, Gulani V, Deshmane A, Shah A, Guruprakash DK, Jiang Y, Ma D, Fisher E, Rudick RA, Raza P, Kilbane M, Cohen JA, Sakaie K, Lowe MJ, Griswold MA, Nakamura K. Magnetic resonance fingerprinting in multiple sclerosis. Mult Scler Relat Disord 2023; 79:105024. [PMID: 37783196 DOI: 10.1016/j.msard.2023.105024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2023] [Revised: 08/15/2023] [Accepted: 09/23/2023] [Indexed: 10/04/2023]
Abstract
BACKGROUND In this cross sectional study, we used MRF to investigate tissue properties of normal-appearing white matter, gray matter, and lesions in relapsing remitting MS (n = 21), secondary progressive MS (n = 16) and healthy controls (n = 9). A FISP-based MRF sequence was used for acquisition, imaging time 5 min 15 s. MRF T1 and T2 relaxation times were measured from lesional tissue, normal-appearing frontal white matter, corpus callous, thalamus, and caudate. Differences between healthy controls and MS were examined using ANCOVA adjusted for age and sex. Spearman rank correlations were assessed between T1 and T2 relaxation times and clinical measures. OBJECTIVES To examine brain T1 and T2 values using magnetic resonance fingerprinting (MRF) in healthy controls and MS. METHODS The subjects included 21 relapsing-remitting (RR) MS, 16 secondary progressive (SP) MS, and 9 age- and sex-matched HC without manifest neurological disease participating in a longitudinal MRI study. A 3T/ FISP-based MRF sequence was acquired. Regions of interest were drawn for lesions and normal appearing white matter. ANCOVA adjusted for age and sex were used to compare the groups with significance set at 0.05. RESULTS A step-wise increase in T1 and T2 relaxation times was found between healthy controls, relapsing remitting MS, and secondary progressive MS. Significant differences were found in T1 and T2 between MS and healthy controls in the frontal normal-appearing white matter, corpus callosum, and thalamus (p < 0.04 for all). Significant differences in T1 and T2 between RR and SPMS were found in the frontal normal-appearing white matter and T2 lesions (p < 0.02 for all). T1 relaxation from the frontal normal-appearing white matter correlated with the Expanded Disability Status Scale [ρ = 0.62, p < 0.001], timed 25 foot walk (ρ = 0.45, p = 0.01), 9 hole peg test (ρ = 0.62, p < 0.001), and paced auditory serial addition test (ρ = -0.4, p = 0.01). CONCLUSION These results suggest that MRF may be a clinically feasible quantitative approach for characterizing tissue damage in MS.
Collapse
Affiliation(s)
- Daniel Ontaneda
- Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, United States.
| | - Vikas Gulani
- Department of Radiology, University of Michigan, Michigan, United States
| | - Anagha Deshmane
- Magnetic Resonance Center, Max Planck Institute for Biological Cybernetics, Tübingen, Germany
| | - Amisha Shah
- Department of Biomedical Engineering, Case Western Reserve University, Cleveland, United States
| | - Deepti K Guruprakash
- Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, United States
| | - Yun Jiang
- Department of Biomedical Engineering, Case Western Reserve University, Cleveland, United States; Department of Radiology, University of Michigan, Ann Arbor, United States
| | - Dan Ma
- Department of Biomedical Engineering, Case Western Reserve University, Cleveland, United States
| | - Elizabeth Fisher
- Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, United States
| | - Richard A Rudick
- Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, United States
| | - Praneeta Raza
- Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, United States
| | - Meghan Kilbane
- Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, United States
| | - Jeffrey A Cohen
- Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, United States
| | - Ken Sakaie
- Imaging Institute, Cleveland Clinic, Cleveland, United States
| | - Mark J Lowe
- Imaging Institute, Cleveland Clinic, Cleveland, United States
| | - Mark A Griswold
- Department of Biomedical Engineering, Case Western Reserve University, Cleveland, United States
| | - Kunio Nakamura
- Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, United States
| |
Collapse
|
2
|
Naji Y, Mahdaoui M, Klevor R, Kissani N. Artificial Intelligence and Multiple Sclerosis: Up-to-Date Review. Cureus 2023; 15:e45412. [PMID: 37854769 PMCID: PMC10581506 DOI: 10.7759/cureus.45412] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/17/2023] [Indexed: 10/20/2023] Open
Abstract
Multiple sclerosis (MS) remains a challenging neurological disorder for the clinician in terms of diagnosis and management. The growing integration of AI-based algorithms in healthcare offers a golden opportunity for clinicians and patients with MS. AI models are based on statistical analyses of large quantities of data from patients including "demographics, genetics, clinical and radiological presentation." These approaches are promising in the quest for greater diagnostic accuracy, tailored management plans, and better prognostication of disease. The use of AI in multiple sclerosis represents a paradigm shift in disease management. With ongoing advancements in AI technologies and the increasing availability of large-scale datasets, the potential for further innovation is immense. As AI continues to evolve, its integration into clinical practice will play a vital role in improving diagnostics, optimizing treatment strategies, and enhancing patient outcomes for MS. This review is about conducting a literature review to identify relevant studies on AI applications in MS. Only peer-reviewed studies published in the last four years have been selected. Data related to AI techniques, advancements, and implications are extracted. Through data analysis, key themes and tendencies are identified. The review presents a cohesive synthesis of the current state of AI and MS, highlighting potential implications and new advancements.
Collapse
Affiliation(s)
- Yahya Naji
- Neurology Department, REGNE Research Laboratory, Faculty of Medicine and Pharmacy, Ibn Zohr University, Agadir, MAR
- Neurology Department, Agadir University Hospital, Agadir, MAR
| | - Mohamed Mahdaoui
- Neurology Department, University Hospital Mohammed VI, Marrakech, MAR
- Neuroscience Research Laboratory, Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech, MAR
| | - Raymond Klevor
- Neurology Department, University Hospital Mohammed VI, Marrakech, MAR
- Neuroscience Research Laboratory, Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech, MAR
| | - Najib Kissani
- Neurology Department, University Hospital Mohammed VI, Marrakech, MAR
- Neuroscience Research Laboratory, Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech, MAR
| |
Collapse
|
3
|
Gaur S, Panda A, Fajardo JE, Hamilton J, Jiang Y, Gulani V. Magnetic Resonance Fingerprinting: A Review of Clinical Applications. Invest Radiol 2023; 58:561-577. [PMID: 37026802 PMCID: PMC10330487 DOI: 10.1097/rli.0000000000000975] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/08/2023]
Abstract
ABSTRACT Magnetic resonance fingerprinting (MRF) is an approach to quantitative magnetic resonance imaging that allows for efficient simultaneous measurements of multiple tissue properties, which are then used to create accurate and reproducible quantitative maps of these properties. As the technique has gained popularity, the extent of preclinical and clinical applications has vastly increased. The goal of this review is to provide an overview of currently investigated preclinical and clinical applications of MRF, as well as future directions. Topics covered include MRF in neuroimaging, neurovascular, prostate, liver, kidney, breast, abdominal quantitative imaging, cardiac, and musculoskeletal applications.
Collapse
Affiliation(s)
- Sonia Gaur
- Department of Radiology, Michigan Medicine, Ann Arbor, MI
| | - Ananya Panda
- All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
| | | | - Jesse Hamilton
- Department of Radiology, Michigan Medicine, Ann Arbor, MI
| | - Yun Jiang
- Department of Radiology, Michigan Medicine, Ann Arbor, MI
| | - Vikas Gulani
- Department of Radiology, Michigan Medicine, Ann Arbor, MI
| |
Collapse
|
4
|
Menon RG, Sharafi A, Muccio M, Smith T, Kister I, Ge Y, Regatte RR. Three-dimensional multi-parameter brain mapping using MR fingerprinting. RESEARCH SQUARE 2023:rs.3.rs-2675278. [PMID: 36993561 PMCID: PMC10055680 DOI: 10.21203/rs.3.rs-2675278/v1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 03/31/2023]
Abstract
The purpose of this study was to develop and test a 3D multi-parameter MR fingerprinting (MRF) method for brain imaging applications. The subject cohort included 5 healthy volunteers, repeatability tests done on 2 healthy volunteers and tested on two multiple sclerosis (MS) patients. A 3D-MRF imaging technique capable of quantifying T1, T2 and T1ρ was used. The imaging sequence was tested in standardized phantoms and 3D-MRF brain imaging with multiple shots (1, 2 and 4) in healthy human volunteers and MS patients. Quantitative parametric maps for T1, T2, T1ρ, were generated. Mean gray matter (GM) and white matter (WM) ROIs were compared for each mapping technique, Bland-Altman plots and intra-class correlation coefficient (ICC) were used to assess repeatability and Student T-tests were used to compare results in MS patients. Standardized phantom studies demonstrated excellent agreement with reference T1/T2/T1ρ mapping techniques. This study demonstrates that the 3D-MRF technique is able to simultaneously quantify T1, T2 and T1ρ for tissue property characterization in a clinically feasible scan time. This multi-parametric approach offers increased potential to detect and differentiate brain lesions and to better test imaging biomarker hypotheses for several neurological diseases, including MS.
Collapse
Affiliation(s)
| | | | | | - Tyler Smith
- New York University Grossman School of Medicine
| | - Ilya Kister
- New York University Grossman School of Medicine
| | - Yulin Ge
- New York University Grossman School of Medicine
| | | |
Collapse
|
5
|
Mostardeiro TR, Panda A, Campeau NG, Witte RJ, Larson NB, Sui Y, Lu A, McGee KP. Correction to: Whole brain 3D MR fingerprinting in multiple sclerosis: a pilot study. BMC Med Imaging 2021; 21:137. [PMID: 34579664 PMCID: PMC8474701 DOI: 10.1186/s12880-021-00673-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Affiliation(s)
| | - Ananya Panda
- Department of Radiology, Mayo Clinic, 200 1st St SW, Rochester, MN, USA
| | - Norbert G Campeau
- Department of Radiology, Mayo Clinic, 200 1st St SW, Rochester, MN, USA
| | - Robert J Witte
- Department of Radiology, Mayo Clinic, 200 1st St SW, Rochester, MN, USA
| | - Nicholas B Larson
- Department of Quantitative Health Sciences, Mayo Clinic, 200 1st St SW, Rochester, MN, USA
| | - Yi Sui
- Department of Radiology, Mayo Clinic, 200 1st St SW, Rochester, MN, USA
| | - Aiming Lu
- Department of Radiology, Mayo Clinic, 200 1st St SW, Rochester, MN, USA
| | - Kiaran P McGee
- Department of Radiology, Mayo Clinic, 200 1st St SW, Rochester, MN, USA
| |
Collapse
|